O

OrisDX

3 employees

OrisDX provides a saliva-based molecular detection method to check oral cavity pre-malignancies and cancers.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Medical

Date founded

2021

Funding rounds raised

Total raised

$665K

from 1 investors over 1 rounds

O

OrisDX raised $665K on June 7, 2022

Investors: Polsky Center at the University of Chicago

FAQ